Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Prevalence study of gastrointestinal risk factors in patients with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis receiving treatment with non- steroidal anti- inflammatory drugs.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Provision of subject informed consent.
Female and/or male, aged \> 21 years.
Patients diagnosis with RA (ACR 1987 or ACR/EULAR 2010 criteria), OA (ACR 1986, 1990 and 1991 criteria) or AS (New York 1984 criteria or ESSG 2002 criteria) (documented in the medical record).
Patients receiving at least one dose of NSAIDs.
You may not be if
Participation in any interventional study involving investigational drugs.
Patient refuses to fill in the study questionnaires.
Pregnant or breastfeeding women.
Patients with active neoplastic disease in the last 5 years, except basal-cell carcinoma.
Clareo Health | Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
